← FDA Drug Approvals (Drugs@FDA)

ZIMHI

NDA · New Drug Application · Sponsor: ZMI PHARMA · Approved 2021-10-15

Drug application

FDA Application #

NDA212854

Application type

New Drug Application

Brand name

ZIMHI

Generic name

NALOXONE HYDROCHLORIDE

Active ingredients

NALOXONE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ZMI PHARMA

Manufacturer

ZMI Pharma Inc.

First approval

2021-10-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown